Quantbot Technologies LP cut its stake in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 84.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 19,044 shares of the company's stock after selling 105,795 shares during the period. Quantbot Technologies LP's holdings in American Healthcare REIT were worth $577,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in AHR. Invesco Ltd. grew its stake in shares of American Healthcare REIT by 1,543.1% during the 1st quarter. Invesco Ltd. now owns 5,022,455 shares of the company's stock valued at $152,180,000 after buying an additional 4,716,792 shares during the period. Vanguard Group Inc. boosted its position in American Healthcare REIT by 22.4% during the 1st quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company's stock worth $569,494,000 after purchasing an additional 3,437,861 shares during the period. Nuveen LLC purchased a new stake in American Healthcare REIT during the 1st quarter worth $68,097,000. Northern Trust Corp boosted its position in American Healthcare REIT by 99.0% during the 4th quarter. Northern Trust Corp now owns 1,732,882 shares of the company's stock worth $49,249,000 after purchasing an additional 861,882 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in American Healthcare REIT during the 1st quarter worth $13,384,000. 16.68% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages recently weighed in on AHR. Baird R W raised shares of American Healthcare REIT to a "strong-buy" rating in a research report on Thursday, July 17th. Scotiabank reaffirmed an "outperform" rating on shares of American Healthcare REIT in a research report on Thursday. JMP Securities upped their price target on shares of American Healthcare REIT from $40.00 to $45.00 and gave the stock a "market outperform" rating in a research report on Monday, August 11th. Robert W. Baird began coverage on shares of American Healthcare REIT in a research report on Friday, July 18th. They set an "outperform" rating and a $41.00 price target for the company. Finally, Morgan Stanley upped their price target on shares of American Healthcare REIT from $37.00 to $45.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 20th. One research analyst has rated the stock with a Strong Buy rating and ten have given a Buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $41.89.
Check Out Our Latest Stock Report on American Healthcare REIT
American Healthcare REIT Stock Up 0.2%
AHR stock traded up $0.07 during trading on Friday, reaching $42.79. The stock had a trading volume of 988,676 shares, compared to its average volume of 1,607,473. American Healthcare REIT, Inc. has a 1-year low of $20.15 and a 1-year high of $43.14. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $7.21 billion, a P/E ratio of -194.48, a PEG ratio of 2.19 and a beta of 1.09. The firm has a fifty day moving average price of $38.75 and a 200 day moving average price of $34.08.
American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The firm had revenue of $542.50 million for the quarter, compared to analyst estimates of $539.49 million. During the same quarter in the previous year, the business posted $0.33 EPS. The firm's revenue was up 7.5% compared to the same quarter last year. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. On average, equities analysts anticipate that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current year.
American Healthcare REIT Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were issued a $0.25 dividend. The ex-dividend date was Monday, June 30th. This represents a $1.00 dividend on an annualized basis and a yield of 2.3%. American Healthcare REIT's payout ratio is currently -454.55%.
Insider Activity
In other news, CIO Stefan K.L. Oh sold 3,860 shares of the company's stock in a transaction dated Monday, June 30th. The shares were sold at an average price of $36.10, for a total value of $139,346.00. Following the sale, the executive owned 95,671 shares in the company, valued at approximately $3,453,723.10. This represents a 3.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.00% of the company's stock.
American Healthcare REIT Company Profile
(
Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Recommended Stories

Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.